Literature DB >> 6750190

Hypertension in chronic glomerulonephritis.

K Onoyama.   

Abstract

In 74 chronic glomerulonephritis (CGN) and 13 hemodialysis patients (HD) blood volume and hemodynamic indices were examined. Significant correlation was observed between MPA and PV in CGN. High PV in high S-Cr group is considered to be correlated with anemia. Salt restriction reduced MAP without the change in BV in the impaired kidney function group in CGN. Volume depletion in HD shifted TPRI to lower level in the group with significant MAP reduction. The results indicate that sodium rather than water will play an important role in this type of hypertension.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6750190     DOI: 10.2169/internalmedicine1962.21.149

Source DB:  PubMed          Journal:  Jpn J Med        ISSN: 0021-5120


  1 in total

1.  Therapeutic benefits and safety of carvedilol in the treatment of renal hypertension. An open, short term study. Carvedilol Renal Hypertension Study Group in Japan.

Authors:  M Kohno; T Takeda; M Ishii; T Saruta; Y Mizuno; M Yoshimura; S Kubo; K Fukiyama; M Fujishima
Journal:  Drugs       Date:  1988       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.